Entry |
|
Name |
Pegteograstim (INN) |
Sequence |
MTPLGPASSL PQSFLLKSLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ QMEELGMAPA LQPTQGCAMP AFASAFQRRA GGVLVASHLQ SFLEVSYRVL RHLAQP (Disulfide bridge: 37-43, 65-75) |
Type |
Peptide |
Class |
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
|
Remark |
|
Efficacy |
Antineutropenic, Granulocyte colony stimulating factor (G-CSF) |
Target |
|
Pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AA Colony stimulating factors
L03AA17 Pegteograstim
D11026 Pegteograstim (INN)
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
D11026 Pegteograstim
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
CSF3R (GCSFR, CD114)
D11026 Pegteograstim (INN)
|
Other DBs |
|
LinkDB |
|